April 9 (Reuters) - Granules India (GRAN.NS), opens new tab is increasing oversight at its manufacturing facilities and digitising documents after the U.S. drug regulator flagged violations, including ...
Hyderabad: Pharma player Granules India Limited on Thursday said a packaging facility of its US step-down subsidiary, Granules Consumer Health LLC, successfully completed a GMP inspection by the US ...
Hyderabad: Granules India Ltd has set up two advanced research centres of excellence (CoEs) at IIT Hyderabad's (IITH) Technology Research Park – the Ascelis CoE for Peptide Development and ...
https://www.thehindubusinessline.com/companies/granules-india-opens-two-coes-at-iit-hyderabad/article70345042.ece Copy Granules India inaugurated two advanced Centres ...
Nov 13 (Reuters) - Paracetamol maker Granules India (GRAN.NS), opens new tab reported a 34% jump in its second-quarter profit on Thursday, driven by strong demand in its key European and North ...
Generic drugmaker Granules India subsidiary Granules Life Sciences (GLS), located in Hyderabad, has received U.S. Food and Drug Administration (U.S. FDA) approval for a product that earlier this year ...
Granules Life Sciences (GLS), an arm of Granules India, has received its first approval from the US Food and Drug Administration (USFDA) for its Hyderabad facility. The approval was for a product for ...
Scientists found that stabilizing stress granules suppresses the effects of ALS-causing mutations, correcting previous models that imply stress granules promote amyloid formation. Scientists from St.
Did you eat cereal this morning? Or have you walked on a gravel path? Maybe you had a headache and had to take a pill? If you answered any of these questions with a yes, you interacted with a granular ...
Shortly after making an M&A play to break into the CDMO business, Granules’ manufacturing bona fides have come under fire in a newly published rebuke by the U.S. FDA. In a warning letter dated Feb. 26 ...
Granules India shares tumble almost 8% after USFDA issues warning letter for its Gagillapur facility
Shares of Granules India tumbled nearly 8 percent in intra-day trade on February 28, 2025, after the United States Food and Drug Administration (US FDA) issued a warning letter to the company’s ...
Granules India shares have tanked 14 percent since the start of the year. Granules India Ltd has received a Warning Letter from the US Food and Drug Administration (FDA) for its Gagillapur facility, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results